RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.08B
AUM Growth
-$217M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
68
New
Increased
Reduced
Closed

Top Buys

1
+$174M
2
+$103M
3
+$74.5M
4
TSHA icon
Taysha Gene Therapies
TSHA
+$58.4M
5
APGE icon
Apogee Therapeutics
APGE
+$42.1M

Top Sells

1
+$365M
2
+$47.4M
3
+$30.3M
4
DSGN icon
Design Therapeutics
DSGN
+$18.7M
5
CVAC icon
CureVac
CVAC
+$11.2M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$56.2M 1.11%
5,587,333
27
$53.7M 1.06%
4,691,178
28
$53M 1.04%
4,163,211
+1,093,680
29
$51.5M 1.01%
11,609,704
30
$48.4M 0.95%
4,417,259
31
$48.2M 0.95%
1,137,444
32
$46.2M 0.91%
5,963,565
33
$46M 0.91%
4,810,508
34
$42.1M 0.83%
+1,977,901
35
$41.3M 0.81%
8,131,952
36
$40.9M 0.81%
6,416,998
37
$37.6M 0.74%
6,809,404
-5,488,317
38
$36.6M 0.72%
+1,239,000
39
$35.8M 0.7%
9,459,678
+6,450,000
40
$34.6M 0.68%
13,150,849
41
$30.8M 0.61%
2,007,946
42
$30.6M 0.6%
1,762,000
43
$30.2M 0.6%
3,178,476
44
$30.1M 0.59%
4,398,453
45
$29.9M 0.59%
+204,500
46
$29M 0.57%
2,122,465
47
$26.9M 0.53%
3,370,506
48
$20.8M 0.41%
+1,483,697
49
$17.1M 0.34%
6,718,483
+651,000
50
$16.1M 0.32%
+800,000
1
2
3